Skip to main content
. 2021 Aug 10;18(16):8440. doi: 10.3390/ijerph18168440

Table 2.

Summary of studies included in the systematic review (k = 13).

Authors
(Years)
Study Design Participants (n) Intervention Control Outcome (Measurements)
1 Li et al.
(2007) [18]
One group pre-posttest design Healthy male, aged 37~55 years (12)
Mean age: 43.1 ± 6.1
A three-day/two-night trip
First day: walked for two hours in the afternoon in a forest field
Second day: walked for two hours each in the morning and afternoon in two different forest field
On day 3: finished the trip
None · NK cells **↑, NK activity **↑,
· T cells
· granulysin **↑, perforin **↑,
granzymes A **↑/B **↑
· WBC, (Lymphocytes *↑, Monocytes*↑,
Granulocytes **↓)
· T-A *↓, D *↓, A-H, F, C, V **↑(POMS)
· the hours of sleep
2 Li et al.
(2008) [19]
One group pre-posttest design Healthy female nurses, aged 25~43 years (13)
Mean age: 28.8 ± 4.6
A three-day/two-night trip
First day: walked for two hours in the afternoon in a forest field
Second day: walked for two hours each in the morning and afternoon in two different forest field
On day 3: finished the trip
None · NK cells **↑, NK activity **↑
· T cells *↓
· granulysin **↑, perforin **↑,
granzymes A **↑/B **↑
· Adrenalin **↓, noradrenaline (Urine) **↓
· Estradiol, progesterone
· T-A, D **↓, A-H, F, C, V (POMS)
3 Li et al.
(2008) [20]
None-equivalent control group pre-posttest design Healthy male, aged 35~56 years (E:12, C:11)
Mean age: 45.1 ± 6.7
A three-day/two-night forest bathing program
First day: walked for two hours in the afternoon in a forest field
Second day: walked for two hours each in the morning and afternoon in two different forest field
On day 3: finished the trip
A three-day/two-night city trip
First day: walked for two hours in the afternoon in an old-style district in the city
Second day: walked for two hours around baseball Dome in the morning and 2 h around/in airport in the afternoon
On day 3: finished the trip
· NK cells *↑, NK activity *↑
· T cells
· granulysin **↑, perforin **↑,
and granzymes A **↑/B **↑
· WBC
· Adrenaline (Urine) *↓
4 Mao et al.
(2012) [21]
RCT Healthy male university students
(E:10, C:10)
Mean age: 20.79 ± 0.54
two-night trip
walked for 1.5 h each in the morning and afternoon in a forest field
walked for 1.5 h each in the morning and afternoon in a city site · NK cells
· T cell, B cell *↑, T-helper cells. suppressor cells, natural killer cells
· IL-6*↓, TNF-α *↓
· T-SOD, MDA **↓
· ET-1 **↓, Platelet activation
· Cortisol *↓, Testosterone
· T-A *↓, D *↓, A-H *↓, F *↓, C, V *↑(POMS)
5 Nakau et al.
(2013) [22]
One group pre-posttest design Breast cancer or lung cancer (22)
Mean age: 58.1 ± 10.8
Walking in the forest, Horticultural therapy, yoga meditation, and support group therapy, and sessions were conducted once a week for 12 weeks None · NK activity **↑
· Well-being of functional and spiritual (FACIT-Sp): GP, GS, GE, GF *↑, Sp *↑
· Quality of life (SF-36): PF *↑, RP *↑, BP,
GH *↑, VT **↑, SF, RE *↑, MH *↑
· Fatigue (CFS) **↓
· T-A *↓, D, A-H, F, C **↓, V (POMS)
· STAI: State anxiety **↓, Trait anxiety *↓
6 Jung et al.
(2015) [27]
None-equivalent control group pre-posttest design Workers in the healthcare and counseling service industries (E:19, C:20)
Mean age
E: 29.42 ± 8.92, C:36.45 ± 12.23
3 days, 2 nights, Walking and meditation in the forest, and exposure to a psychological program using music and cognitive-behavioral therapy. frequently use the environment without participating in the program · NK activity
· Cortisol *↑
· HRV
· MBI-GS **↓, WRSI *↓, REQ **↑
7 Kim et al.
(2015) [28]
One group pre-posttest design Stage 3 Breast cancer patient, aged 25~60 years (11)
Mean age: 56 ± 5.12 (11)
Stay in the forest for 14 days, Forest therapy program (Walk, forest life) None · NK cells **↑
· Perforin *↑, Granzyme B *↑
8 Jia et al.
(2016) [29]
RCT elderly patients
with chronic obstructive pulmonary disease (E: 10, C: 8)
Mean age
E: 70.1 C: 70
4 days, walking in the forest (total 3 h walk/day) 4 days, walking in the city (total 3 h walk/day) · NK cells, NKT-like cell, CD8+ T cells
· Perforin **↓, Granzyme B
· IL-6 *↓, IL-8 **↓, interleukin-1β *↓, TNF-α
interferon-γ *↓, CRP *↓
· Cortisol *↓, Epinephrine *↓
· RARC/CCL-18 **↓, TIMP-1 *↓, SP-D *↓
· T-A **↓, D *↓, A-H *↓, F, C, V (POMS)
9 Han et al.
(2016) [30]
None-equivalent control group pre-posttest design Full-time employees with chronic widespread pain for more than three months, aged 25~49 years
(E: 33, C: 28)
Mean age
E: 41.6 ± 6.5, C: 37.5 ± 8.4
2 days forest therapy program
Walking and therapeutic activities in the forest activities (music therapy, psycho-education: coping with pain and stress, bodily exercises, mindfulness-based meditation)
The control group was instructed not to conduct either heavy loads of domestic or occupational work during the enrollment in this study. · NK activity **↑
· Heart rate variability (HRV) **↑
· Self-reported pain **↓ (VAS)
· Depression **↓ (BDI)
· Health-related quality of life **↑ (EQ-VAS)
10 Mao et al.
(2017) [31]
RCT Elderly patients with chronic heart failure, Aged from 65 to 80 years
(E: 23, C: 10)
Mean age
73.86 ± 5.85 years old
4 days, Walking in the forest (total 3 h walk/day) 4 days, Walking in the city (total 3 h walk/day) · IL-6 *↓, TNF-α, CRP
· BNP **↓, N-terminal pro BNP
· ET-1 **↓, Renin, AGT, Ang II, AT1, AT2 **↑
· T-SOD *↑, MDA *↓
· T-A *↓, D **↓, A-H **↓, F, C **↓, V (POMS)
11 Lee et al.
(2017) [32]
None-equivalent control group pre-posttest design Women in their 50 s (E: 9, C: 9)
Mean age
E: 53.9 ± 2.69, C: 55.5 ± 1.84
Forest walking exercise for 12 weeks (3 times/week, 110 min/day) Ground walking exercise for 12 weeks (3 times/week, 110 min/day) · NK cells *↑
· Melatonin *↑
12 Tsao et al.
(2018) [33]
One group pre-post test design Middle-aged subjects (11)
Mean age: 60.4
A five-day/four-night trip (maintain dietary control and walking exercise)
First day: walked for 1.5 h in the afternoon in a forest field
Next three days: walked for 1.5 h each in the morning and afternoon in two different forest field
Fifth day: finished the trip
None · NK cells, NK activity **↑
13 Lyu et al.
(2019) [34]
None-equivalent control group pre-posttest design Male College Students
(E: 45, C: 15)
Mean age
E: 20.9 ± 0.24, C: 21.3 ± 0.45
Bamboo forest site exposure for three days City site exposure for three days · NK cells *↑. NK activity *↑,
· granulysin, perforin *↑,
granzymes A *↑/B *↑,
· corticosterone *↓
· SBP *↓, DBP, HR, SpO2
· T-A *↓, D *↓, A-H *↓, F *↓, C *↓, V *↑ (POMS)

*: p < 0.05; **: p < 0.01; ↑: indicators rise; ↓: indicators decline; E = Experimental group; C = Control group; POMS = Profile of mood states; T-A = Tension-anxiety; D = Depression: A-H = Anger-hostility,; F = fatigue; C = Confusion; V = Vigor; WBC = hite blood cell; IL-6 = Interleukin-6; TNF-α = Tumor necrosis factors α; T-SOD = Total superoxide dismutase; MDA = Activity and malondialdehyde; ET-1 = Endothelin-1; FACIT-Sp = Functional assessment of chronic illness therapy-spiritual; GP = Physical well-being; GS = Social/family well-being; GE = Emotional well-being; GF = Functional well-being; Sp = Spiritual well-being; CFS = Cancer fatigue scale; SF-36 = 36-Item short-form health survey; PF = Physical functioning; RP = Role-physica; BP = Bodily pain; GH = General health perception; VT = Vitality; SF = social functioning; RE = Role emotional; MH = Mental health; STAI = State-trait anxiety inventory; HRV = Heart rate variability; MBI-GS = Maslach Burnout Inventory-General Survey; WRSI = Worker’s Stress Response Inventory; REQ = Recovery Experience Questionnaire; CRP = C-peptide protein; RARC/CCL-18= Pulmonary and activation-regulated chemokine, TIMP-1= Tissue inhibitor of metalloproteinase-1; SP-D = Surfactant protein D; VAS: Visual analog scale; BDI = Beck Depression Inventory; EQ-VAS= EuroQol Visual Analog Scale; BNP = Brain natriureti; AGT = Angiotensinogen; Ang II = Angiotensin II; AT1 = Angiotensin II type 1 receptor; AT2 = Angiotensin II type 2 receptor; SBP = Systolic blood pressure; DBP = Diastolic blood pressure; HR = Heart rate.